Cefuroxime Sodium for Injection with GMP 0.75g 1.5g

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For external use
Still deciding? Get samples of US$ 0.001/Piece
Request Sample
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
4950
Management System Certification
ISO9001:2015, ISO14001:2015, OHSAS18001:2007, GMP, GMP, GMP, GMP, GMP, GMP
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
  • Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Find Similar Products

Basic Info.

Model NO.
0.75g 1.5g
Suitable for
Elderly, Children, Adult
State
Solid
Shape
Oral Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
H20013187
Indate
3years
Sterile
Sterile
Color
White
Standard
Bp/Cp
Transport Package
50vials/Tray/Box, 20boxes/Carton
Specification
0.6g 1.2g
Trademark
Reyoung
Origin
China
HS Code
3003101900
Production Capacity
20000000vials/Year

Product Description

Product name Cefuroxime Sodium for Injection
Specificaton 0.75g 1.5g
Certification GMP ISO9001 ISO14001
Standard BP/CP
fuction It is suitable for moderate and severe infection caused by pathogenic bacteria producing or not producing lactamase, lower respiratory tract infection, pneumonia, acute attack of chronic bronchitis, acute bronchitis, lung abscess and other lung infections; urinary system infection, acute glomerulonephritis, acute attack of chronic glomerulonephritis, complex urinary tract infection, abdominal infection, peritonitis, cholecystitis, bile duct Inflammation and other intra-abdominal infections, pelvic infections, pelvic inflammation and other infections. Sepsis, meningitis, skin and soft tissue infections.
taboo Allergic to cefuroxime or other cephalosporins..
Announcements Cefuroxime is the second generation of broad-spectrum semi synthetic cephalosporins. Cefuroxime has strong antibacterial activity against almost all strains sensitive to cefotaxime and cefotaxime, and is effective against a wide range of gram-negative bacilli, including Enterobacter and indole positive proteus. The clinical and bacteriological effective rate of cefuroxime in the treatment of respiratory tract, five sense organs, bone, soft tissue infection, meningitis and simple urinary tract infection was 70% - 100%, and the prevention of postoperative infection was also satisfactory. Cefuroxime is very effective in the treatment of acute gonorrhea and urinary tract infection caused by Neisseria gonorrhoeae. 169 cases of gonorrhea were treated by intramuscular injection of cefuroxime at a single dose of 1.5g. The blister disappeared in 160 cases within 1-5 days after intramuscular injection. The cure rate was 97.7%. The short-term and long-term bacteriological cure rates of cefuroxime were 55% and 48%




Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g
Cefuroxime Sodium for Injection with GMP 0.75g 1.5g




















 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier